Amgen | A Worldwide Pioneer in Biotechnology
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Products - Amgen
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. With a presence in approximately 100 countries, we are proud to have reached millions of people with our products.
Amgen - Wikipedia
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total. [5]
Amgen Inc. (AMGN) Stock Price, News, Quote & History - Yahoo Finance
Find the latest Amgen Inc. (AMGN) stock quote, history, news and other vital information to help you with your stock trading and investing.
AMJEVITA™ (ADALIMUMAB-ATTO), FIRST BIOSIMILAR TO HUMIRA ... - Amgen
Jan 31, 2023 · reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis, alone or in combination with methotrexate or other non-biologic DMARDs.
Discover Amgen and Search Our Jobs and Careers in Biotechnology
Live. Win. Thrive. We dare to ask questions that lead to lifesaving treatments. Join us in pushing the boundaries of biotechnology in a career at Amgen.
AMGN Stock Price | Amgen Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
3 days ago · AMGN | Complete Amgen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA
2 days ago · THOUSAND OAKS, Calif., Nov. 13, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today issued the following statement on the MariTide (maridebart cafraglutide, formerly AMG 133) Phase 1 data. "As previously stated, Amgen does not see an association between the administration of MariTide and bone mineral density changes. The Phase 1 study results do not suggest any bone safety concern or change our ...
Amgen Pipeline
Amgen Pipeline. Download pipeline chart. A robust pipeline leveraging state-of-the-art science and molecular engineering focused on the pursuit of transformative medicines with large effects in serious diseases. Human genetic validation is used to strengthen the evidence base of as many of our programs as possible.
Amgen dismisses bone density concerns related to its weight-loss …
2 days ago · Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after those concerns wiped off more than $12 billion from the company's ...